Biography

Prof. Dhruv Kumar has been ranked world’s top 2% scientist by STANFORD in the area of Oncology and Cancer Biology

After earning B.Sc. in Chemistry from Banaras Hindu University (BHU), Varanasi and M.Sc. in Bioinformatics with Distinction from the University of Allahabad (AU), Prayagraj, Dr. Dhruv Kumar completed his Ph.D. in Cellular, Molecular and Industrial Biology from the University of Bologna (UNIBO), Italy under one of the prestigious fellowships of Ministry of Human Resource and Development (MHRD), Indo-Italian Government fellowship. After completion of his PhD, he received five years of Postdoctoral training from the School of Medicine, University of Kansas Medical Center, Kansas City, USA.

Currently, he is working as a Professor of Cancer Biology and Molecular Medicine at School of Health Science and Technology (SoHST), UPES University, Dehradun, Uttarakhand, India. He has researched on several cancers, including Prostate, Pancreatic, Brain, Breast, Gallbladder, Endometrial and Head and Neck Cancer focusing on understanding the molecular mechanism (s) of the regulation of Autophagy and Apoptosis in Cancer Stem Cells (Prostate, Pancreatic, Brain and Breast).

Specifically, he studied the molecular mechanism (s) of induced Autophagy in Cancer Stem Cells (CSCs) via PI3K/Akt/mTOR signaling pathways and molecular cross-talk between the tumor microenvironment (Cancer Associated Fibroblast (CAF)) and Head and Neck Squamous Cell Carcinoma (HNSCC) via HGF/c-MET and bFGF/FGFR signaling pathways, intra-tumor mutational heterogeneity. Currently, his lab is exploring the Autophagy-Metabolic axis in cancer cells (head and neck, oral, breast, and brain) and tumor microenvironment for the development of therapeutic approach.

Apart from his research, he is actively involved in teaching courses at UG, PG and PhD level related to Cancer Biology, Stem Cell Biology, Molecular Medicine and Bioinformatics. He has received several national and international fellowships and awards and published more than hundreds of articles in high impact journals.